ArticleToxicon: X2021
Implications of global environmental change for the burden of snakebite.
Article in Toxicon: X, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of variables associated with snakebite risk in spatial and temporal analyses.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025Pooled it
- Strengthening public health programmes and the antivenom ecosystem: strategic policy priorities to combat envenomation by animal bites and stings in Latin America and the Caribbean.Journal of global health · 2026Article
- Persistent spatial hotspots and socioeconomic inequalities of snakebite envenoming in Peru: A nationwide spatiotemporal analysis, 2010-2025.PLoS neglected tropical diseases · 2026Article
- Immunological Cross-Reactivity and Neutralizing Efficacy of Antivenom Against Five Medically Important Iranian Viper Venoms.Veterinary medicine and science · 2026Article
- Behavioural and environmental risk factors associated with snake-human conflict: A scoping systematic review.PLoS neglected tropical diseases · 2026Article
- Climate change triggering shifts in venomous snakes hotspots and snakebite risk in India.Scientific reports · 2025Article
- Nationwide variation of snakebite incidence in Kenya: Community surveys as an integrated NTD approach.PLoS neglected tropical diseases · 2025Article
- Causal inference unveils how forest coverage mitigates excess snakebite cases during rainfall seasons in Colombia.Scientific reports · 2025Article
- Future of snakebite risk in India: Consequence of climate change and the shifting habitats of the big four species in next five decades.PLoS neglected tropical diseases · 2025Article
- When the bite is not the threat: non-venomous snakebites and their impact on rural child health.BMJ paediatrics open · 2025Article
- Article
- Participatory research towards the control of snakebite envenoming and other illnesses in a riverine community of the Western Brazilian Amazon.PLoS neglected tropical diseases · 2025Article
- Barriers to the hospital treatment among Bede snake charmers in Bangladesh with special reference to venomous snakebite.PLoS neglected tropical diseases · 2023Article
- Analysis of News Media-Reported Snakebite Envenoming in Nepal during 2010-2022.PLoS neglected tropical diseases · 2023Article
- Identifying high snakebite risk area under climate change for community education and antivenom distribution.Scientific reports · 2023Article
- Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues.Toxicon: X · 2023Article
- A generalized framework for estimating snakebite underreporting using statistical models: A study in Colombia.PLoS neglected tropical diseases · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Snakebite envenoming is a set of intoxication diseases that disproportionately affect people of poor socioeconomic backgrounds in tropical countries. As it is highly dependent on the environment its burden is expected to shift spatially with global anthropogenic environmental (climate, land use) and demographic change. The mechanisms underlying the changes to snakebite epidemiology are related to factors of snakes and humans. The distribution and abundance of snakes are expected to change with global warming via their thermal tolerance, while rainfall may affect the timing of key activities like feeding and reproduction. Human population growth is the primary cause of land-use change, which may impact snakes at smaller spatial scales than climate via habitat and biodiversity loss (e.g. prey availability). Human populations, on the other hand, could experience novel patterns and morbidity of snakebite envenoming, both as a result of snake responses to environmental change and due to the development of agricultural adaptations to climate change, socioeconomic and cultural changes, development and availability of better antivenoms, personal protective equipment, and mechanization of agriculture that mediate risk of encounters with snakes and their outcomes. The likely global effects of environmental and demographic change are thus context-dependent and could encompass both increasing and or snakebite burden (incidence, number of cases or morbidity), exposing new populations to snakes in temperate areas due to "tropicalization", or by land use change-induced snake biodiversity loss, respectively. Tackling global change requires drastic measures to ensure large-scale ecosystem functionality. However, as ecosystems represent the main source of venomous snakes their conservation should be accompanied by comprehensive public health campaigns. The challenges associated with the joint efforts of biodiversity conservation and public health professionals should be considered in the global sustainability agenda in a wider context that applies to neglected tropical and zoonotic and emerging diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.